Oyster Point Pharma, Inc. (OYST) CEO Jeffrey Nau on Q2 2021 Results – Earnings Call Transcript

Oyster Point Pharma, Inc. (OYST) Q2 2021 Earnings Conference Call August 5, 2021 4:30 PM ET
Company Participants
Daniel Lochner – Chief Financial Officer
Jeffrey Nau – President and Chief Executive Officer
John Snisarenko – Chief Commercial Officer
Conference…

Click here to view the original article.